サワイグループホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/05/20 | 1,747.5 | 1,772 | 1,732.5 | 1,754 | +23 | +1.3% | 577,300 |
2025/05/19 | 1,751 | 1,751 | 1,718 | 1,731 | -41 | -2.3% | 719,300 |
2025/05/16 | 1,802.5 | 1,826.5 | 1,763 | 1,772 | -10 | -0.6% | 721,200 |
2025/05/15 | 1,720 | 1,794 | 1,689.5 | 1,782 | +46 | +2.6% | 1,469,600 |
2025/05/14 | 1,920 | 1,920 | 1,650 | 1,736 | -207.5 | -10.7% | 1,293,100 |
2025/05/13 | 1,970.5 | 1,974 | 1,919 | 1,943.5 | -26.5 | -1.3% | 717,300 |
2025/05/12 | 1,978.5 | 1,986.5 | 1,941.5 | 1,970 | -20 | -1% | 480,600 |
2025/05/09 | 1,992.5 | 1,997 | 1,979 | 1,990 | -6 | -0.3% | 390,600 |
2025/05/08 | 2,002 | 2,016 | 1,986 | 1,996 | -20.5 | -1% | 418,100 |
2025/05/07 | 2,026 | 2,049.5 | 2,002 | 2,016.5 | -17 | -0.8% | 431,300 |
2025/05/02 | 2,035.5 | 2,064 | 2,025.5 | 2,033.5 | -22.5 | -1.1% | 520,600 |
2025/05/01 | 2,069 | 2,083 | 2,039.5 | 2,056 | +6.5 | +0.3% | 308,300 |
2025/04/30 | 2,059.5 | 2,067 | 2,043.5 | 2,049.5 | +8.5 | +0.4% | 357,200 |
2025/04/28 | 2,056 | 2,059 | 2,032.5 | 2,041 | -2.5 | -0.1% | 453,600 |
2025/04/25 | 2,044 | 2,053 | 2,030.5 | 2,043.5 | -0.5 | ±0% | 264,600 |
2025/04/24 | 2,049 | 2,068 | 2,023 | 2,044 | +6 | +0.3% | 289,100 |
2025/04/23 | 2,050 | 2,052 | 2,021.5 | 2,038 | +33.5 | +1.7% | 328,700 |
2025/04/22 | 1,979.5 | 2,022.5 | 1,952 | 2,004.5 | +33.5 | +1.7% | 500,800 |
2025/04/21 | 1,968 | 1,973 | 1,947.5 | 1,971 | +11 | +0.6% | 193,400 |
2025/04/18 | 1,953 | 1,978 | 1,934 | 1,960 | +46.5 | +2.4% | 209,100 |
2025/04/17 | 1,912 | 1,919 | 1,902.5 | 1,913.5 | -11 | -0.6% | 214,800 |
2025/04/16 | 1,911.5 | 1,924.5 | 1,892.5 | 1,924.5 | +19.5 | +1% | 306,700 |
2025/04/15 | 1,897 | 1,909 | 1,893.5 | 1,905 | +10 | +0.5% | 272,500 |
2025/04/14 | 1,892 | 1,913 | 1,882 | 1,895 | +32.5 | +1.7% | 447,700 |
2025/04/11 | 1,850 | 1,864.5 | 1,820 | 1,862.5 | -52.5 | -2.7% | 427,100 |
2025/04/10 | 1,834.5 | 1,917 | 1,828 | 1,915 | +90.5 | +5% | 764,900 |
2025/04/09 | 1,830.5 | 1,845 | 1,796 | 1,824.5 | -33.5 | -1.8% | 808,500 |
2025/04/08 | 1,850 | 1,867.5 | 1,821.5 | 1,858 | +49 | +2.7% | 697,000 |
2025/04/07 | 1,817.5 | 1,862 | 1,794.5 | 1,809 | -128.5 | -6.6% | 831,500 |
2025/04/04 | 1,919.5 | 1,958 | 1,906 | 1,937.5 | -2.5 | -0.1% | 552,400 |
2025/04/03 | 1,900 | 1,955.5 | 1,893 | 1,940 | +0.5 | ±0% | 746,400 |
2025/04/02 | 1,980 | 1,980 | 1,936.5 | 1,939.5 | -60.5 | -3% | 402,200 |
2025/04/01 | 2,000 | 2,011.5 | 1,988 | 2,000 | +18.5 | +0.9% | 511,100 |
2025/03/31 | 2,011 | 2,015 | 1,957 | 1,981.5 | -65 | -3.2% | 671,400 |
2025/03/28 | 2,055 | 2,072.5 | 2,033 | 2,046.5 | -53.5 | -2.5% | 513,400 |
2025/03/27 | 2,096.5 | 2,102.5 | 2,074 | 2,100 | +3.5 | +0.2% | 480,200 |
2025/03/26 | 2,085 | 2,106 | 2,080.5 | 2,096.5 | -3.5 | -0.2% | 430,600 |
2025/03/25 | 2,105 | 2,129 | 2,085 | 2,100 | -28.5 | -1.3% | 416,000 |
2025/03/24 | 2,105 | 2,158 | 2,100.5 | 2,128.5 | +26.5 | +1.3% | 917,200 |
2025/03/21 | 2,094 | 2,118.5 | 2,091.5 | 2,102 | +3.5 | +0.2% | 667,300 |
2025/03/19 | 2,103 | 2,125.5 | 2,096 | 2,098.5 | -1.5 | -0.1% | 321,000 |
2025/03/18 | 2,070 | 2,117 | 2,067 | 2,100 | +39.5 | +1.9% | 576,300 |
2025/03/17 | 2,060 | 2,067.5 | 2,045 | 2,060.5 | -10 | -0.5% | 317,000 |
2025/03/14 | 2,062 | 2,072 | 2,036.5 | 2,070.5 | +3.5 | +0.2% | 368,000 |
2025/03/13 | 2,080 | 2,080 | 2,056.5 | 2,067 | -19 | -0.9% | 370,900 |
2025/03/12 | 2,024 | 2,102 | 2,021.5 | 2,086 | +41 | +2% | 646,900 |
2025/03/11 | 2,029.5 | 2,068.5 | 2,006 | 2,045 | -18 | -0.9% | 875,800 |
2025/03/10 | 2,050 | 2,091.5 | 2,048 | 2,063 | +2 | +0.1% | 546,900 |
2025/03/07 | 2,049.5 | 2,147.5 | 2,035.5 | 2,061 | -8 | -0.4% | 1,138,500 |
2025/03/06 | 2,085.5 | 2,090 | 2,059.5 | 2,069 | -35 | -1.7% | 591,500 |
1~
50
件表示中 / 1010件
類似銘柄と比較する
現在ご覧いただいている「サワイGHD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
サワイGHD | 175,400円 | +5.9% | +24.5% | 3.14% | 11.64倍 | 1.10倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
日本新薬 | 340,100円 | +8.0% | -15.3% | 3.65% | 9.55倍 | 0.93倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
ペプチド | 172,500円 | +5.0% | +1.5% | 0.00% | 14.75倍 | 3.93倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
キッセイ薬 | 388,500円 | +3.6% | +6.1% | 3.09% | 13.09倍 | 0.77倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
市場注目の銘柄
チャート関連のコラム